National Research (NASDAQ:NRC) Hits New 1-Year High – Here’s What Happened

National Research Corporation (NASDAQ:NRC)’s share price reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $23.00 and last traded at $22.2450, with a volume of 5181 shares. The stock had previously closed at $22.40.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on NRC shares. Citizens Jmp assumed coverage on National Research in a research report on Monday, June 22nd. They set a “market outperform” rating and a $23.00 price objective for the company. Weiss Ratings upgraded National Research from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, May 29th. One research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, National Research has a consensus rating of “Moderate Buy” and a consensus target price of $23.00.

National Research Stock Performance

The firm’s 50-day simple moving average is $19.31 and its two-hundred day simple moving average is $18.00. The company has a current ratio of 0.52, a quick ratio of 0.52 and a debt-to-equity ratio of 5.48. The stock has a market capitalization of $515.06 million, a PE ratio of 58.05 and a beta of 0.35.

National Research (NASDAQ:NRC) last released its earnings results on Tuesday, April 28th. The company reported $0.21 earnings per share (EPS) for the quarter. The company had revenue of $34.80 million during the quarter. National Research had a return on equity of 122.73% and a net margin of 6.52%.

National Research Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 10th. Investors of record on Friday, June 26th will be paid a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 2.8%. The ex-dividend date of this dividend is Friday, June 26th. National Research’s dividend payout ratio is currently 164.10%.

Institutional Trading of National Research

A number of hedge funds have recently made changes to their positions in the stock. Russell Investments Group Ltd. boosted its holdings in shares of National Research by 85.6% during the third quarter. Russell Investments Group Ltd. now owns 1,997 shares of the company’s stock worth $26,000 after purchasing an additional 921 shares during the period. EverSource Wealth Advisors LLC increased its stake in National Research by 9,535.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,638 shares of the company’s stock valued at $28,000 after buying an additional 1,621 shares during the period. BNP Paribas Financial Markets increased its stake in National Research by 85.4% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,496 shares of the company’s stock valued at $32,000 after buying an additional 1,150 shares during the period. Strs Ohio purchased a new stake in National Research in the 1st quarter worth approximately $33,000. Finally, Raymond James Financial Inc. purchased a new stake in National Research in the 2nd quarter worth approximately $34,000. 47.26% of the stock is owned by hedge funds and other institutional investors.

National Research Company Profile

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.